Can GDF-15 Predict Bleeding Risk in VTE? – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Timothy Hoberstorfer et al., adding:
“Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism
Growth differentiation factor-15 has been proposed as a marker of bleeding risk, but it did not deliver here.
In patients anticoagulated for acute venous thromboembolism, GDF-15 levels showed no association with clinically relevant bleeding and added nothing to existing bleeding prediction.
The result argues against using this biomarker to guide anticoagulation decisions in VTE.”
Title: Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism
Authors: Timothy Hoberstorfer, Stephan Nopp, Daniel Steiner, Cornelia Englisch, Philip Kienzl, Benedikt Weber, Monika Fritzer-Szekeres, Ingrid Pabinger, Cihan Ay
Other articles about Journal of Thrombosis and Haemostasis on Hemostasis Today.
-
Sep 19, 2026, 18:03Manisha Madkaikar: Clinical, Hematological, and Molecular Features of Sickle β-Thalassemia
-
Sep 19, 2026, 17:24Jan Shawqi Goran: Understanding Beta Thalassemia Before Marriage Testing
-
Sep 19, 2026, 14:17Abdul Mannan: What Exactly Is a Platelet?
-
Sep 19, 2026, 13:39Keisuke Goda: Decoding Platelet Phenotypes in COVID-19 With Optofluidic Imaging
-
Sep 19, 2026, 13:30Targeted Thrombolysis Beyond tPA
-
Sep 19, 2026, 13:21Paul Armstrong: From Summer Studentship to Young Researcher
-
Sep 19, 2026, 13:06Rabiya Masood: Breaking the Cycle of Thalassemia Through Screening
-
Sep 19, 2026, 10:52Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment
-
Sep 19, 2026, 10:47Amber Yates: Inside Agios’ Partnership with the Sickle Cell Community